Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with non-Hodgkin lymphoma or multiple myeloma, confirmed by a pathology test
- People who are scheduled to receive one of the following FDA-approved CAR-T cell therapies: Axi-cel, Liso-cel, Tisa-cel, Ide-cel, Cilta-cel, or Brexu-cel
- People aged 18 or older
- People with a general health and activity level that falls within a certain range, as assessed by their doctor using a standard scale called the ECOG Performance Status (score of 0, 1, or 2) (confirm with trial site)
- People who own a smartphone and are able to use it to make twice-daily voice recordings
- People who are able to complete daily neurological (brain and nervous system) check-ins, such as simple assessments of thinking and movement
- People who can speak English well enough to complete structured voice tasks in the study app (native-level fluency is not required)
Who may not be able to join:
- People who have a pre-existing neurological condition that significantly affects their speech, such as severe difficulty forming words, loss of ability to express language, or a degenerative brain or nerve condition
- People with a history of significant speech or voice disorders, such as paralysis of the voice box, severe voice problems, or recent surgery or radiation to the throat area
- People with any condition affecting the vocal cords that could interfere with voice analysis, such as vocal cord paralysis, chronic laryngitis, nodules, polyps, growths, or tumours on the vocal cords
- People with severe hearing loss that would interfere with completing the voice assessments
- People who have a language barrier that would prevent them from reliably completing the voice tasks or allowing the study team to interpret the results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Roni Shouval, MD, PhD, Memorial Sloan Kettering Cancer Center
Phone: 646-888-3483
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of daily voice recordings collected; Number of neurocognitive assessments collected
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.